Metagenomi Therapeutics (MGX) Tax Provisions (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Tax Provisions of $10000.0 for Q1 2026, down 89.8% year-over-year from $98000.0 in Q1 2025, and down 70.59% quarter-over-quarter from $34000.0 in Q4 2025.
Metagenomi Therapeutics (MGX) Tax Provisions (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of Tax Provisions data on file, last reported at $10000.0 in Q1 2026.
- Tax Provisions for Q1 2026 came in at $10000.0, down 89.8% year-over-year; the trailing twelve-month figure through Mar 2026 was -$146000.0 (up 97.3% YoY), and the FY2025 annual result was -$58000.0, up 98.95% from the prior year.
- Tax Provisions slipped to $10000.0 in Q1 2026 per MGX's latest filing, from $34000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $2.7 million in Q4 2023 and troughed at -$2.2 million in Q2 2024.
- A 4-year average of -$160666.7 and a median of $22000.0 in 2025 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2024 and 2025: Tax Provisions plunged 274.63% in 2024, then surged 102.81% in 2025.
- A 4-year view of Tax Provisions shows it stood at $2.7 million in 2023, then slumped by 144.31% to -$1.2 million in 2024, then surged by 102.81% to $34000.0 in 2025, then tumbled by 70.59% to $10000.0 in 2026.
- Business Quant data shows MGX's Tax Provisions at $10000.0 in Q1 2026, $34000.0 in Q4 2025, and -$234000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Metagenomi Therapeutics | 46.60 Mn | 46.60 Mn | - | 10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | -234,000.00 |
| Jun 30, 2025 | 44,000.00 |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | -2.11 Mn |
| Jun 30, 2024 | -2.20 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | -2.20 Mn |